Compass Therapeutics (CMPX) Institutional Ownership $3.49 0.00 (0.00%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$3.52 +0.03 (+1.00%) As of 08/29/2025 07:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Compass Therapeutics (NASDAQ:CMPX)CurrentInstitutional OwnershipPercentage68.43%Number ofInstitutional Buyers(last 12 months)49TotalInstitutional Inflows(last 12 months)$35.27MNumber ofInstitutional Sellers(last 12 months)33TotalInstitutional Outflows(last 12 months)$50.63M Get CMPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Compass Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data CMPX Institutional Buying and Selling by Quarter Compass Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 Marex Group plc23,600$61K0.0%N/A0.017% 8/15/2025 Bank of America Corp DE32,549$85K0.0%-91.5%0.024% 8/15/2025 Adage Capital Partners GP L.L.C.4,424,868$11.51M0.0%+11.3%3.200% 8/14/2025 MPM Bioimpact LLC5,622,505$14.62M2.5%-33.4%4.066% 8/14/2025 Orbimed Advisors LLC15,219,994$39.57M1.1%-31.9%11.006% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.50,164$130K0.0%-17.8%0.036% 8/14/2025 The Manufacturers Life Insurance Company 35,553$92K0.0%-10.0%0.026% 8/14/2025 Vivo Capital LLC6,043,466$15.71M1.6%+70.0%4.370% 8/13/2025 Invesco Ltd.58,735$153K0.0%+58.1%0.042% 8/13/2025 Panagora Asset Management Inc.15,840$41K0.0%-90.7%0.011% Get the Latest News and Ratings for CMPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Compass Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 8/12/2025 XTX Topco Ltd32,415$84K0.0%N/A0.023% 8/12/2025 American Century Companies Inc.27,607$72K0.0%-62.5%0.020% 8/12/2025 Rhumbline Advisers113,487$295K0.0%-5.5%0.082% 8/12/2025 JPMorgan Chase & Co.2,125,717$5.53M0.0%-2.7%1.537% 8/8/2025 Intech Investment Management LLC44,223$115K0.0%-43.5%0.032% 8/8/2025 Creative Planning11,484$30K0.0%N/A0.008% 8/8/2025 SG Americas Securities LLC372,681$969K0.0%-60.4%0.270% 8/8/2025 Geode Capital Management LLC2,319,132$6.03M0.0%-1.9%1.677% 7/25/2025 Sequoia Financial Advisors LLC16,485$43K0.0%-41.0%0.012% 7/22/2025 Simplicity Wealth LLC84,636$220K0.0%+81.8%0.061% 6/27/2025 Goldman Sachs Group Inc.233,522$444K0.0%-40.2%0.169% 5/29/2025 Rhumbline Advisers120,029$228K0.0%-7.0%0.087% 5/28/2025 Strs Ohio17,900$34K0.0%N/A0.013% 5/16/2025 Goldman Sachs Group Inc.233,522$444K0.0%-40.2%0.169% 5/16/2025 Adage Capital Partners GP L.L.C.3,975,000$7.55M0.0%-33.7%2.875% 5/15/2025 Birchview Capital LP24,000$46K0.0%N/A0.017% 5/15/2025 MPM Bioimpact LLC8,442,783$16.04M2.8%-1.5%6.105% 5/15/2025 Baker BROS. Advisors LP547,498$1.04M0.0%-64.9%0.396% 5/15/2025 Propel Bio Management LLC228,317$434K0.5%N/A0.165% 5/14/2025 MetLife Investment Management LLC37,167$71K0.0%-41.1%0.027% 5/14/2025 Walleye Trading LLC25,000$48K0.0%N/A0.018% 5/14/2025 Walleye Capital LLC52,478$100K0.0%N/A0.038% 5/14/2025 Wellington Management Group LLP222,505$423K0.0%N/A0.161% 5/13/2025 American Century Companies Inc.73,682$140K0.0%N/A0.053% 5/12/2025 Nuveen LLC304,504$579K0.0%N/A0.220% 5/9/2025 Deutsche Bank AG102,041$194K0.0%N/A0.074% 5/9/2025 Charles Schwab Investment Management Inc.297,880$566K0.0%+4.1%0.215% 5/1/2025 New York State Common Retirement Fund30,407$58K0.0%-20.4%0.022% 4/29/2025 Bank of New York Mellon Corp243,565$463K0.0%+2.3%0.176% 4/28/2025 Vontobel Holding Ltd.29,882$57K0.0%N/A0.022% What Steve Bannon revealed about Trump’s gold play (Ad)A Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your IRA could be at risk. Here’s how to prepare.Download the Free Gold Protection Guide to get started now4/21/2025 Catalina Capital Group LLC16,938$32K0.0%-65.4%0.012% 4/17/2025 Exchange Traded Concepts LLC54,207$103K0.0%-44.6%0.039% 4/15/2025 SG Americas Securities LLC940,784$1.79M0.0%+138.2%0.680% 4/15/2025 Simplicity Wealth LLC46,543$88K0.0%N/A0.034% 4/8/2025 Rhumbline Advisers120,029$228K0.0%-7.0%0.087% 2/17/2025 Squarepoint Ops LLC24,072$35K0.0%N/A0.017% 2/17/2025 Two Sigma Advisers LP51,000$74K0.0%-41.0%0.037% 2/17/2025 Two Sigma Investments LP145,238$211K0.0%-24.8%0.106% 2/17/2025 Tang Capital Management LLC5,900,000$8.56M0.6%+225.4%4.288% 2/17/2025 ProShare Advisors LLC28,722$42K0.0%+49.0%0.021% 2/17/2025 MPM Bioimpact LLC8,567,896$12.42M1.8%+51.9%6.227% 2/17/2025 Millennium Management LLC33,857$49K0.0%-80.0%0.025% 2/17/2025 Enavate Sciences GP LLC7,788,150$11.29M8.1%N/A5.660% 2/17/2025 DAFNA Capital Management LLC158,394$230K0.1%+35.5%0.115% 2/17/2025 Cantor Fitzgerald L. P.100,000$145K0.0%-44.4%0.073% 2/17/2025 Bank of America Corp DE113,020$164K0.0%+36.6%0.082% 2/17/2025 BNP Paribas Financial Markets18,562$27K0.0%N/A0.013% 2/14/2025 Monashee Investment Management LLC448,164$650K0.1%-10.4%0.326% 2/14/2025 Northern Trust Corp801,225$1.16M0.0%-5.1%0.582% 2/14/2025 Voya Investment Management LLC32,561$47K0.0%-13.5%0.024% 2/14/2025 Blue Owl Capital Holdings LP2,954,712$4.28M1.0%+2.6%2.147% 2/14/2025 Adage Capital Partners GP L.L.C.5,994,810$8.69M0.0%-46.1%4.357% 2/14/2025 Price T Rowe Associates Inc. MD46,942$69K0.0%+31.8%0.034% 2/14/2025 Rock Springs Capital Management LP5,779,575$8.38M0.3%+2.7%4.201% 2/14/2025 Tower Research Capital LLC TRC17,251$25K0.0%+298.0%0.013% 2/14/2025 MetLife Investment Management LLC63,141$92K0.0%+200.3%0.046% 2/13/2025 XTX Topco Ltd52,754$76K0.0%+160.9%0.038% 2/13/2025 Mariner LLC20,673$30K0.0%N/A0.015% 2/13/2025 Barclays PLC192,766$279K0.0%+13.2%0.140% 2/13/2025 Renaissance Technologies LLC278,600$404K0.0%+25.2%0.202% 2/13/2025 Invesco Ltd.39,483$57K0.0%+11.3%0.029% 2/13/2025 Wells Fargo & Company MN59,860$87K0.0%+27.8%0.044% 2/12/2025 Geode Capital Management LLC2,334,171$3.39M0.0%+1.1%1.696% 2/12/2025 Alliancebernstein L.P.21,440$31K0.0%-11.3%0.016% 2/12/2025 JPMorgan Chase & Co.272,328$395K0.0%+512.5%0.198% 2/11/2025 Corebridge Financial Inc.50,704$74K0.0%-7.0%0.037% 2/11/2025 LPL Financial LLC45,000$65K0.0%-10.0%0.033% 2/11/2025 Intech Investment Management LLC51,924$75K0.0%+218.7%0.038% 2/10/2025 Connor Clark & Lunn Investment Management Ltd.156,871$227K0.0%-32.4%0.114% 2/7/2025 Sequoia Financial Advisors LLC30,876$45K0.0%N/A0.022% 2/7/2025 Independent Advisor Alliance17,948$26K0.0%N/A0.013% 2/4/2025 Bank of New York Mellon Corp237,975$345K0.0%+2.6%0.173% 1/30/2025 Rhumbline Advisers129,116$187K0.0%+3.1%0.094% 1/27/2025 Bleakley Financial Group LLC39,993$58K0.0%+250.7%0.029% 1/24/2025 Catalina Capital Group LLC48,964$71K0.0%N/A0.036% 1/17/2025 SG Americas Securities LLC395,017$573K0.0%+921.6%0.287% 11/19/2024 Barclays PLC170,245$314K0.0%+195.4%0.124% 11/16/2024 Geode Capital Management LLC2,309,778$4.25M0.0%+0.8%1.679% 11/15/2024 Barclays PLC170,245$314K0.0%+195.4%0.124% 11/15/2024 XTX Topco Ltd20,221$37K0.0%N/A0.015% Everyone’s watching Nvidia right now. Here’s why I’m excited. (Ad)So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.🎯 Click here to watch the video and get the free ticker XGPT just flagged.11/15/2024 Jane Street Group LLC73,487$135K0.0%-52.0%0.053% 11/15/2024 Janus Henderson Group PLC1,843,286$3.36M0.0%-64.7%1.340% 11/13/2024 FMR LLC4,136,273$7.61M0.0%+0.1%3.006% 11/13/2024 The Manufacturers Life Insurance Company42,671$79K0.0%N/A0.031% 11/9/2024 Intech Investment Management LLC16,292$30K0.0%N/A0.012% 11/1/2024 Rovin Capital UT ADV13,495$25K0.0%N/A0.010% 10/10/2024 Exchange Traded Concepts LLC97,931$180K0.0%-12.6%0.071% 10/3/2024 SG Americas Securities LLC38,665$71K0.0%+16.6%0.028% 9/16/2024 Cubist Systematic Strategies LLC40,701$41K0.0%N/A0.030% 8/14/2024 Cubist Systematic Strategies LLC40,701$41K0.0%N/A0.030% (Data available from 1/1/2016 forward) CMPX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CMPX shares? During the previous two years, 83 institutional investors and hedge funds held shares of Compass Therapeutics. The most heavily invested institutionals were Orbimed Advisors LLC ($39.57M), Vivo Capital LLC ($15.71M), MPM Bioimpact LLC ($14.62M), Blackstone Inc. ($12.19M), Adage Capital Partners GP L.L.C. ($11.51M), Enavate Sciences GP LLC ($11.29M), and Tang Capital Management LLC ($8.56M).Learn more on Compass Therapeutics' institutional investors. What percentage of Compass Therapeutics' stock is owned by institutional investors? 68.43% of Compass Therapeutics' stock is owned by institutional investors. Learn more on CMPX's institutional investor holdings. Which institutional investors have been buying Compass Therapeutics' stock? Of the 62 institutional investors that purchased Compass Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Enavate Sciences GP LLC ($7.79M), Tang Capital Management LLC ($4.09M), Opaleye Management Inc. ($3.17M), MPM Bioimpact LLC ($2.93M), Vivo Capital LLC ($2.49M), SG Americas Securities LLC ($955.26K), and Adage Capital Partners GP L.L.C. ($579.87K). How much institutional buying is happening at Compass Therapeutics? Institutional investors have bought a total of 21,289,510 shares in the last 24 months. This purchase volume represents approximately $35.27M in transactions. Which of Compass Therapeutics' major shareholders have been selling company stock? Of the 33 institutional investors that sold Compass Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($7.16M), Orbimed Advisors LLC ($7.14M), Janus Henderson Group PLC ($3.37M), MPM Bioimpact LLC ($2.95M), Baker BROS. Advisors LP ($1.01M), SG Americas Securities LLC ($568.10K), and Bank of America Corp DE ($350.95K). How much institutional selling is happening at Compass Therapeutics? Institutional investors have sold a total of 23,939,760 shares in the last 24 months. This volume of shares sold represents approximately $50.63M in transactions. Related Companies IMCR Major Shareholders BHVN Major Shareholders WVE Major Shareholders AUPH Major Shareholders TVTX Major Shareholders EWTX Major Shareholders SDGR Major Shareholders AVDL Major Shareholders ARDX Major Shareholders JANX Major Shareholders This page (NASDAQ:CMPX) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Compass Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Compass Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CMPX Stock Alerts